MedTrace Logo

Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis

NCT04862819 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-04-28

No results posted yet for this study

Summary

The aim of the planned randomized clinical trial will be the clinical and microbiological evaluation of the new intracellular drug developed in cooperation with the Chair and Department of Drug Form Technology of the Medical University and the Department and Department of Pharmaceutical Microbiology and Parasitology of the Medical University in Wrocław.

Conditions

  • Periodontitis

Interventions

DRUG

new local drug delivery

In the first group, on one side of the dental arch, the drug under evaluation will be used, and on the other side srp

PROCEDURE

scaling root planing

In the second group, on one side of the dental arch srp will be performed

Sponsors & Collaborators

  • Wroclaw Medical University

    lead OTHER

Principal Investigators

  • Małgorzata Szulc, phd · wroclaw medical univeristy

  • Tomasz Konopka, prof · wroclaw medical univeristy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2021-11-01
Completion
2021-12-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04862819 on ClinicalTrials.gov